Preparation and in vitro antiproliferative effect of tocotrienol loaded lipid nanoparticles

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 353, Issue 1, 2010, Pages 43-51

  Ali, Hazem ^a   Shirode, Amit B ^a   Sylvester, Paul W ^a   Nazzal, Sami ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

Antiproliferation; Factorial design; Nanostructured lipid carriers; Solid lipid nanoparticles; Stability; Tocotrienol

Indexed keywords

CELL CULTURE; CELLS; HOMOGENIZATION METHOD; POLYDISPERSITY; SIMULATED ANNEALING; SURFACE ACTIVE AGENTS; ULTRASONIC IMAGING; VEGETABLE OILS;

ANTIPROLIFERATIVE EFFECT; BREAST CANCER; FACTORIAL DESIGN; FULL FACTORIAL DESIGN; IN-VITRO; LIPID NANOPARTICLES; LIPID PHASE; MAMMARY EPITHELIAL CELLS; NANOSTRUCTURED LIPID CARRIERS; PALM OIL; POTENTIAL VALUES; PRIMARY OBJECTIVE; SOLID LIPID NANOPARTICLES; STABILITY STUDY; TOCOTRIENOLS; TOTAL LIPIDS; ULTRASONIC HOMOGENIZATION;

NANOPARTICLES;

ALPHA TOCOTRIENOL; LIPID NANOPARTICLE; NANOCARRIER; PALM OIL; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISPERSION; DRUG MECHANISM; DRUG STABILITY; FACTORIAL ANALYSIS; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MITOSIS INHIBITION; NANOENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; ULTRASOUND;

EID: 71249125643     PISSN: 09277757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2009.10.020     Document Type: Article

References (32)

1. McIntyre B.S., Briski K.P., Gapor A., and Sylvester P.W. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neo-plastic mouse mammary epithelial cells. Proceedings of the Society for Experimental Biology and Medicine 224 (2000) 292-301
2. Shah S., and Sylvester P.W. Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells. Experimental Biology and Medicine 229 (2004) 745-755
3. Samant G.V., and Sylvester P.W. gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells. Cell Proliferation 39 (2006) 563-574
4. Yap S.P., Yuen K.H., and Lim A.B. Influence of route of administration on the absorption and disposition of alpha-, gamma- and delta-tocotrienols in rats. Journal of Pharmacy and Pharmacology 55 (2003) 53-58
5. Castelli F., Puglia C., Sarpietro M.G., Rizza L., and Bonina F. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. International Journal of Pharmaceutics 304 (2005) 231-238
6. 1H-NMR study. International Journal of Pharmaceutics 205 (2000) 15-21
7. Müller R.H., Radtke M., and Wissing S.A. Nanostructured lipid matrices for improved microencapsulation of drugs. International Journal of Pharmaceutics 242 (2002) 121-128
8. Almeida A.J., Runge S., and Muller R.H. Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters. International Journal of Pharmaceutics 149 (1997) 155-165
9. Siekmann B., and Westesen K. Investigation on solid lipid nanoparticles prepared by precipitation in o/w emuslion. European Journal of Pharmaceutics and Biopharmaceutics 43 (1996) 104-109
10. M.R. Gasco, Method for producing solid lipid microspheres having a narrow size distribution, US Patent No. 5,250,236 (1993).
11. Hu F.Q., Jiang S.P., Du Y.Z., Yuan H., Ye Y.Q., and Zeng S. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids and Surfaces 45 (2005) 167-173
12. Saupe A., Gordon K.C., and Rades T. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy. International Journal of Pharmaceutics 314 (2006) 56-62
13. Souto E.B., and Muller R.H. The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents. Die Pharmazie 61 (2006) 431-437
14. Mumper R.J., Cui Z., and Oyewumi M.O. Nanotemplate engineering of cell specific nanoparticles. Journal of Dispersion Science and Technology 24 (2003) 569-588
15. Mehnert W., and Mader K. Solid lipid nanoparticles: production, characterization and applications. Advanced Drug Delivery Reviews 47 (2001) 165-196
16. Lin X., Li X., Zheng L., Yu L., Zhang Q., and Liu W. Preparation and characterization of monocaprate nanostructured lipid carriers. Colloids and Surfaces A 311 (2007) 106-111
17. Huang G., Zhang N., Bi X., and Dou M. Solid lipid nanoparticles of temozolomide: potential reduction of cardial and nephric toxicity. International Journal of Pharmaceutics 355 (2008) 314-320
18. Suresh G., Manjunath K., Venkateswarlu V., and Satyanarayana V. Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles. AAPS PharmSciTech 8 (2007) 24
19. Charcosset C., El-Harati A., and Fessi H. Preparation of solid lipid nanoparticles using a membrane contactor. Journal of Controlled Release 108 (2005) 112-120
20. Ahlin P., Kristl J., and Šmid-Kober J. Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions. Acta Pharmaceutica 48 (1998) 257-267
21. ®, Statistical Experiment Design, Data Analysis and Nonlinear Optimization (1994), Wiley, New York
22. Ali H., and Nazzal S. Development and validation of a reversed-phase HPLC method for the simultaneous analysis of simvastatin and tocotrienols in combined dosage forms. Journal of Pharmaceutical and Biomedical Analysis 49 (2009) 950-956
23. Danielson K.G., Anderson L.W., and Hosick H.L. Selection and characterization in culture of mammary tumor cells with distinctive growth properties in vivo. Cancer Research 40 (1980) 1812-1819
24. Jores K., Mehnert W., Drechsler M., Bunjes H., Johann C., and Mader K. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. Journal of Controlled Release 95 (2004) 217-227
25. Dong X., Mattingly C.A., Tseng M., Cho M., Adams V.R., and Mumper R.J. Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization. European Journal of Pharmaceutics and Biopharmaceutics 72 (2009) 9-17
26. Lai F., Wissing S.A., Muller R.H., and Fadda A.M. Artemisia arborescens L essential oil-loaded solid lipid nanoparticles for potential agricultural application: preparation and characterization. AAPS PharmSciTech 7 (2006) 2
27. Goppert T.M., and Muller R.H. Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). European Journal of Pharmaceutics and Biopharmaceutics 60 (2005) 361-372
28. Tiyaboonchai W., Tungpradit W., and Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. International Journal of Pharmaceutics 337 (2007) 299-306
29. Wali V.B., and Sylvester P.W. Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells. Lipids 42 (2007) 1113-1123
30. Serpe L., Catalano M.G., Cavalli R., Ugazio E., Bosco O., Canaparo R., Muntoni E., Frairia R., Gasco M.R., Eandi M., and Zara G.P. Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line. European Journal of Pharmaceutics and Biopharmaceutics 58 (2004) 673-680
31. Yuan H., Miao J., Du Y.Z., You J., Hu F.Q., and Zeng S. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. International Journal of Pharmaceutics 348 (2008) 137-145
32. Jores K., Mehnert W., and Mader K. Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: a nuclear magnetic resonance and electron spin resonance study. Pharmaceutical Research 20 (2003) 1274-1283